These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. The importance of the relationship between microalbuminuria, subclinical proteinuria and arterial hypertension in diabetics. Serban V; Dabelea D Rom J Intern Med; 1994; 32(2):153-8. PubMed ID: 7920330 [TBL] [Abstract][Full Text] [Related]
29. Urinary beta-glucuronidase excretion in insulin-dependent diabetes mellitus: relation with diabetic nephropathy. Rodríguez-Cuartero A; Barcelona-Martín F Clin Nephrol; 1997 Aug; 48(2):135-6. PubMed ID: 9285156 [No Abstract] [Full Text] [Related]
30. Exercise induced proteinuria is an early indicator of diabetic nephropathy. Jauhari J J Assoc Physicians India; 1999 Nov; 47(11):1127-8. PubMed ID: 10862339 [No Abstract] [Full Text] [Related]
31. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Ioannou K Hormones (Athens); 2017 Oct; 16(4):351-361. PubMed ID: 29518755 [TBL] [Abstract][Full Text] [Related]
32. [Monitoring diabetic nephropathy by the determination of microalbuminuria]. Krempf M; Ricolleau G; Murat A; du Rostu H; Charbonnel B; Guillon J Presse Med; 1984 Dec; 13(46):2817. PubMed ID: 6240655 [No Abstract] [Full Text] [Related]
33. Prevention of diabetic nephropathy. Microalbuminuria and perspectives for intervention in insulin-dependent diabetes. Mathiesen ER Dan Med Bull; 1993 Jun; 40(3):273-85. PubMed ID: 8339600 [No Abstract] [Full Text] [Related]
34. Effect of cigarette smoking on urinary podocyte excretion in early diabetic nephropathy. Nakamura T; Kawagoe Y; Koide H Diabetes Care; 2003 Apr; 26(4):1324-5. PubMed ID: 12663629 [No Abstract] [Full Text] [Related]
35. [Urine proteins and excretion of brush-border antigens in the early stages of diabetic nephropathy]. Mutti A; Ghiggeri GM; Alinovi R; Bergamaschi E; Spaggiari M; Franchini I; Queirolo C; Borghetti A Ann Ital Med Int; 1988; 3(1):10-8. PubMed ID: 3152832 [No Abstract] [Full Text] [Related]
36. Screening and treatment of diabetic renal disease. Clement JD; Cottiero RA Med Health R I; 1998 Nov; 81(11):348-9. PubMed ID: 15580788 [No Abstract] [Full Text] [Related]
37. Proteomic identification of urinary biomarkers of diabetic nephropathy. Rao PV; Lu X; Standley M; Pattee P; Neelima G; Girisesh G; Dakshinamurthy KV; Roberts CT; Nagalla SR Diabetes Care; 2007 Mar; 30(3):629-37. PubMed ID: 17327332 [TBL] [Abstract][Full Text] [Related]
38. Urinary measurement of transforming growth factor-beta and type IV collagen as new markers of renal injury: application in diabetic nephropathy. Ellis D; Forrest KY; Erbey J; Orchard TJ Clin Chem; 1998 May; 44(5):950-6. PubMed ID: 9590367 [TBL] [Abstract][Full Text] [Related]
39. Urine markers of podocyte dysfunction: a review of podocalyxin and nephrin in selected glomerular diseases. Akankwasa G; Jianhua L; Guixue C; Changjuan A; Xiaosong Q Biomark Med; 2018 Aug; 12(8):927-935. PubMed ID: 29976076 [TBL] [Abstract][Full Text] [Related]
40. Microalbuminuria--a marker of the risk of developing nephropathy in insulin-dependent diabetes. Dryáková M; Englis M; Bartos V; Rozprimová L; Sidlová A; Malý J Czech Med; 1989; 12(3):181-8. PubMed ID: 2509176 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]